This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by PAOLISSO, G. Articles by LEFÈBVRE, P. J. Search for Related Content PubMed PubMed Citation Articles by PAOLISSO, G. Articles by LEFÈBVRE, P. J.

Pulsatile Insulin Delivery is More Efficient Than Continuous Infusion in Modulating Islet Cell Function in Normal Subjects and Patients with Type 1 Diabetes

Istituto di Clinica Medica and the Department di Geriatria y Gerontologia, First Medical School, University of Naples Naples, Italy
the Division of Diabetes, Department of Medicine, University of Liège Liège, Belgium

Address requests for reprints: P. J. Lefebvre, M.D., C.H.U. Sart Tilman (B. 35), B-4000 Liege 1, Belgium.

The respective modulating effects of continuous and intermittent insulin delivery on pancreatic islet cell function were studied in seven normal men and nine insulin-dependent (type 1) diabetic patients. In the normal men, saline or continuous (0.8 mU kg^–1 min^–1) or pulsatile (5.2 mU kg^–1 min^–1, with a switching on/off length of 2/11 min) human insulin were delivered on different days and in random order. Despite hyper-insulinemia, blood glucose was kept close to its basal value by the glucose clamp technique. The diabetic patients also were infused in random order and on different days with either saline or a smaller amount of insulin delivered continuously (0.15 mU kg^–1 min^–1) or in a pulsatile manner (0.97 mU kg^–1 min^–1 for 2 min, followed by 11 min during which no insulin was infused). In all experiments, 5 g arginine were given iv as a bolus dose 30 min before the end of the study, and plasma C-peptide and glucagon levels were determined to assess islet cell function. In the normal men, insulin administration resulted in a significant decline of basal plasma glucagon and C-peptide levels and in a clear-cut decrease in the arginine-induced glucagon response. These effects of insulin were significantly more marked when insulin was delivered in a pulsatile rather than a continuous manner. In the insulin-dependent diabetic patients, the lower dose of insulin infused continuously did not alter the basal or arginine-stimulated glucagon response. In contrast, when the same amount of insulin was delivered intermittently, arginine-induced glucagon release was greatly reduced. Thus, these data support the concept that insulin per se is a potent physiological modulator of islet A- and B-cell function. Furthermore, they suggest that these effects of insulin are reinforced when the hormone is administered in an intermittent manner in an attempt to reproduce the pulsatile physiological release of insulin.

Received July 13, 1987.

This article has been cited by other articles:

				E. Sargsyan, H. Ortsater, K. Thorn, and P. Bergsten Diazoxide-induced {beta}-cell rest reduces endoplasmic reticulum stress in lipotoxic {beta}-cells J. Endocrinol., October 1, 2008; 199(1): 41 - 50. [Abstract] [Full Text] [PDF]

				M. H. Shanik, Y. Xu, J. Skrha, R. Dankner, Y. Zick, and J. Roth Insulin Resistance and Hyperinsulinemia: Is hyperinsulinemia the cart or the horse? Diabetes Care, February 1, 2008; 31(Supplement_2): S262 - S268. [Abstract] [Full Text] [PDF]

				J.-M. Lin, M. E. Fabregat, R. Gomis, and P. Bergsten Pulsatile Insulin Release From Islets Isolated From Three Subjects With Type 2 Diabetes Diabetes, April 1, 2002; 51(4): 988 - 993. [Abstract] [Full Text] [PDF]

				P. Bergsten, J. Westerlund, P. Liss, and P.-O. Carlsson Primary In Vivo Oscillations of Metabolism in the Pancreas Diabetes, March 1, 2002; 51(3): 699 - 703. [Abstract] [Full Text] [PDF]

				N. Porksen, T. Grofte, J. Greisen, A. Mengel, C. Juhl, J. D. Veldhuis, O. Schmitz, M. Rossle, and H. Vilstrup Human insulin release processes measured by intraportal sampling Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E695 - E702. [Abstract] [Full Text] [PDF]

				P. Bergsten Role of Oscillations in Membrane Potential, Cytoplasmic Ca2+, and Metabolism for Plasma Insulin Oscillations Diabetes, February 1, 2002; 51(90001): S171 - 176. [Abstract] [Full Text] [PDF]

				N. Porksen, M. Hollingdal, C. Juhl, P. Butler, J. D. Veldhuis, and O. Schmitz Pulsatile Insulin Secretion: Detection, Regulation, and Role in Diabetes Diabetes, February 1, 2002; 51(90001): S245 - 254. [Abstract] [Full Text] [PDF]

				J.-M. Lin, H. Ortsater, H. Fakhrai-Rad, J. Galli, H. Luthman, and P. Bergsten Phenotyping of Individual Pancreatic Islets Locates Genetic Defects in Stimulus Secretion Coupling to Niddm1i Within the Major Diabetes Locus in GK Rats Diabetes, December 1, 2001; 50(12): 2737 - 2743. [Abstract] [Full Text] [PDF]

				L. Sha, J. Westerlund, J. H. Szurszewski, and P. Bergsten Amplitude Modulation of Pulsatile Insulin Secretion by Intrapancreatic Ganglion Neurons Diabetes, January 1, 2001; 50(1): 51 - 55. [Abstract] [Full Text]